Literature DB >> 28540834

The cryo-thermal therapy-induced IL-6-rich acute pro-inflammatory response promoted DCs phenotypic maturation as the prerequisite to CD4+ T cell differentiation.

Kun Liu1, Kun He1, Ting Xue2, Ping Liu1,3, Lisa X Xu1,3.   

Abstract

In our previous studies, a novel tumour therapeutic modality of the cryo-thermal therapy has been developed leading to long-term survival in 4T1 murine mammary carcinoma model. The cryo-thermal therapy induced the strong acute inflammatory response and IL-6 was identified in an acute profile. In this study, we found that the cryo-thermal therapy triggered robust acute inflammatory response with high expression of IL-6 locally and systemically. The phenotypic maturation of dendritic cells (DCs) was induced by acute IL-6 following the treatment. The mature DCs promoted CD4+ T cell differentiation. Moreover, the production of interferon γ (IFN γ) in the serum and CD4+ T cells were both abrogated by IL-6 neutralisation following the treatment. Our findings revealed that the cryo-thermal therapy-induced acute IL-6 played an important role in initiating the cascading innate and adaptive anti-tumour immune responses, resulting in CD4+ T cell differentiation. It would be interesting to investigate acute IL-6 as an early indicator in predicating tumour therapeutic effect.

Entities:  

Keywords:  Acute inflammation; DCs maturation; anti-tumour immune response; interleukine-6

Mesh:

Substances:

Year:  2017        PMID: 28540834     DOI: 10.1080/02656736.2017.1332394

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  6 in total

1.  Clinical practice guideline for image-guided multimode tumour ablation therapy in hepatic malignant tumours.

Authors:  G Z Wang; X H He; Y Wang; L C Xu; H Z Huang; Y H Wang; Z Shen; X D Qu; X Y Ding; J J Yang; W T Li
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

2.  Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity.

Authors:  Kun He; Shengguo Jia; Yue Lou; Ping Liu; Lisa X Xu
Journal:  Cell Death Dis       Date:  2019-03-04       Impact factor: 8.469

3.  Co-ablation versus cryoablation for the treatment of stage III-IV non-small cell lung cancer: A prospective, noninferiority, randomized, controlled trial (RCT).

Authors:  Wuwei Yang; Yonghui An; Quanwang Li; Chuanbo Liu; Baorang Zhu; Qianfu Huang; Mengfei Zhao; Fei Yang; Huasong Feng; Kaiwen Hu
Journal:  Thorac Cancer       Date:  2020-12-14       Impact factor: 3.500

4.  Th1-Dominant CD4+ T Cells Orchestrate Endogenous Systematic Antitumor Immune Memory After Cryo-Thermal Therapy.

Authors:  Peng Peng; Yue Lou; Junjun Wang; Shicheng Wang; Ping Liu; Lisa X Xu
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

5.  Neoantigen-specific CD4+ T-cell response is critical for the therapeutic efficacy of cryo-thermal therapy.

Authors:  Peng Peng; Hongming Hu; Ping Liu; Lisa X Xu
Journal:  J Immunother Cancer       Date:  2020-09       Impact factor: 13.751

Review 6.  Hyperthermia Targeting the Tumor Microenvironment Facilitates Immune Checkpoint Inhibitors.

Authors:  Zihui Li; Jie Deng; Jianhai Sun; Yanling Ma
Journal:  Front Immunol       Date:  2020-11-09       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.